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Epidermal tlrowth I'aetor (EGF) has previously t~en shown to stimuhtte =lu~:oneoiileneszs in rat liver by deerea~inl!! the at:ttvity ~f pyruvate kina~¢ 
[(1981~) Biochem. J, 255, ~,61 364). Here we investillate the ra¢chani~ra underlyinll the inaettvtttion of the enzyflt¢, EGF w~s fou=)d to increase the 
in~orl'~ratio~ f phosphate into p~'ruv'=te kinase, with raaxiraal phosphorylation achieved only after 10 rain in tit= preface of the i!rowth factor. 
The increase in phosphorylation was not additive with that caused by cyclic AMP, Phosphoamino acid analysis of pyruvate kinase isolated from 
cells treated with EGF indicated that EGF increases phosphorylation solely on ser,nc residues, The ~xact site of EGF-mediated pho~phorylation 
has yet to be ~dcntified, 
Pyrnvate kinase: Epidermal tzrowth factor; Cyclic AMP: Phosphorylati0n; Hepatocyte 
I, INTRODUCTION 
Hepatocytes contain large numbers of epidermal 
growth factor (EGF) receptors on their cell surface [1], 
and in addition to its well-characterised stimulation of 
DNA synthesis both in rive and in cultured hepatocytes 
[2], EGF has a number of important short-term effects 
on liver cell metabolism. The similarities between the 
EGF receptor and that of insulin has led a number of 
groups to look for parallels in the actions of these two 
effectors, Although EGF does indeed have some effects 
in liver which mimic those of insulin (e.g. increased 
phosphorylation f acetyl-CoA carbo×ylase and ATP- 
citrate lyase [3], stimulation of fatty acid synthesis [3,4] 
and activation of glycogen synthase [5]), some dif- 
ferences have also been noted. 
Recent work in this laboratory has shown that EGF 
exerts two distinct effects on hepatocytes which resem- 
ble those of glucagon rather than insulin. Firstly, both 
EGF and glucagon have been shown to increase the rate 
of Na+/H * exchange in isolated hepatocytes [6]. The 
consequent increase in electroneutral Na* influx causes 
stimulation of the electrogenic Na +, K+-ATPase and 
plasma membrane hyperpolarisation, thus increasing 
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the rate of electrogenic Na*-dependent alanine 
transport [7]. t~lasma membrane hyperpolarisation by
EGF may be an important early event in liver regenera- 
tion. The mechanism by which cAMP and EOF 
stimulate the Na*/H* exchanger is unknown, but 
stimulation by EGF is independent of any changes in 
the intracellular concentration of cAMP [8], Secondly 
we have shown that EGF, like glucagon, produces a
stable decrease inthe activity of pyruvate kinase leading 
to an increase,,., in the rate of gluconeo~e.~esis from a 
number of glucose precursors including lactate, alanine 
and asparagine [8], This effect of EGF is again indepen- 
dent of any change in the intracellular ¢o~:centration f 
cAMP. The work described below shows that the inac- 
tivation of pyruvate kinase by EGF is accompanied by 
an increase in the incorporation of phosphate onto 
serine residues of the enzyme. 
2. MATERIALS AND METHODS 
2,1. Hepatoeyle ~solalion, incubation and extraction 
Rat liver hepatocytes were isolated essentially as described 
previously [7] an~,a suspended at 10-15 mg cell protein/ml in low. 
phosphate mediutr~ (140 mM NaCI, 5 ram KCI, I mM MgSO4, 2.5 
ram CaCla, 0.2 mM KH2PO4, 20 raM Mops, 20/0 w/v BSA). Cells 
were labelled with 32p by incubation plus !00-1 rnCi/ml 3Zp at 37°C 
for 1 h prior to th,~, addition of 30 nM EGF or 50.aM CIPhScAMP. 
After the appropriate time in the presence of effectors, cells were spun 
at 10000×g for 5 s and resuspended in an equal volume of ice.cold 
extraction buffer (50 mM KHzPO4 (pH 7.4), 1130 raM KCl. 50 mM 
NaF. 5 ram EDTA, 2 mM benzamidine, '30 mM potassium 
pyrophosphate, I% Triton X-IOO plus ! /~g/ml Ieupeptin, antipain 
and pepstatin). A, fter a further 2 min tl~e extracts were spun at 
10000 x g for 10 r~ ~in and the supernatant retained, Samples were kept 
at 0-4°C at all tirr:es. 
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Depending on the radioactivity of the pcl, the band rorrcxpundin8 
to pyruvrts kinax Was chhcr idcntifird by ~trnventional Cotlmextir 
brilliant bhte xtainin8 or by autoradiography overnight u~itr# flash- 
presctivatcd X0nat film (Kodak), The pyrurtttc klnttw band Was 
fhen oxcircd and ralubilircd by treatin& in I.5 ml 0r 60% V/Y wf- 
chlorie acid and 1.5 ml 0r 3t)‘?6 v/v EhQ rap 4 Ir a~ ROT. Sflmplst 
wcrc caolcd and the radioactivity was nmxar%ctl by liqrtitl rcintilla~iun 
counting In IS ml lhisalvc E (Koohmtight), 
Pyruvetc kinssc activity was dstcrminstl 11 5 mM phospho. 
cnolpyruvatc as dcncribcd previously [9]. One unit 0rctltp2 activity 
is defined as the imow~ or mryt-rre ctttalyxlng the formation of I 
nmol 0r pyr1~vtw2 rr0nl 5 mhl plios~~ho~cnolpyr~~vt~lc per minute at 
37*c. 
Cdl cxtrxt.s Were prepared from hcpatory~rx incubated with I mCi 
JzP/n~I, and pyruvatc kinasc was separated by irntnunoprceipitltion 
and SDS-PAGE as dcscribcd above. The bm~d eorrcspontling to 
pyruvutc kinssc was exeiscd and the protein extracted by elcctroclu~ 
tion into 20 mM Tris.HCl (pi-i 8.0), 2 mM EDTA and 0.1% (w/v) 
SDS. Thr cleetroclutcd protein was acetone-precipitated and samples 
Were trypsiniscd overni8ht at 30°C with 0,l mg lrypsin/ml in 50 mbl 
ammonium bicarbonate (pH 8.0). The tryptic digests were then 
hydrolysed in 100~~1 of 6 M HCI for I h a~ llO°C. The samples were 
loaded onto 20x20 em c~llulosc TLC plates (Kodak) d011g with 
phospho4erinc, mthrconinc and -tyrosinc as standards. 
Phosphoamino acids wcrc separated by high voltage clcctrophoresis 
at pi-i 3.5 or pEi 1!9as described previously [IO]. “P.Labelled amino 
acids were visrralised by autoradiography for 7 days at - 80°C using 
prcflashed X.Omat S film and intensifier rcrccns. 
2.3. Marerids 
“P was obtained from Amcrsham International (Amcrsham, 
Bucks, UK). EGF, CIPhScAMP, bcrrzamidinc, Tritnn X-100, EDTA 
and Twcen-20 were all from Sigma Chemical Co. (Poole, Dorsct, 
UK). Protease inhibitors were purchased from Cambridge Research 
Biochcmicals (Cambridge, UK) and tosylphrnylalanyl. 
chloromethanc-treated trypsin was from Worthington Diagnostic 
Systems (Freehold. NJ, USA). Protein-A Scpharosc was obtained 
from Bioprocessing Ltd, (Consctt Co., Durham, UK) and collagenax 
was supplied by Boehringer-Mannheim (Lewes, East Sussex, UK). 
3. RESULTS AND DISCUSSION 
The effect of EGF on the phosphorylation of 
pyruvate kinase was determined both quantitatively and 
qualitatively by the immunoprecipitation of pyruvate 
kinase with a rabbit polyclonal anti-rat liver pyruvate 
kinase IgG preparation. Pyruvate kinase was the major 
phosphoprotein immunoprecipitated from hepatocyte 
cell extracts. Fig. I shows that EGF increased the incor- 
poration of phosphate into pyruvate kinase over the 
basal control level. By measuring the pyruvate kinase 
activity remaining in the supernatant after im- 
munoprecipitation, the degree of phosphorylation of 
the enzyme could be quantified. Since both cyclic AMP 
and EGF inactivate pyruvate kinase by increasing the 
K, for phospho-enolpyruvate without altering the V,,, 
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Fig. I. The cffcct of NF on tlic incorporation al ‘:P inta pyruvute 
kinarc, Ccl1 cxtrtxts wcrc prcparctl from ““l’.labclled hrparaeyrca. 
treetcd with EGF or cAMP for IO min. Pyruvarr klnarc wax 
imnrunoprsoipitntcrl and xrparatrtl bySRS.PA(jE,Thcd~grccof”ZP. 
incorporation Was assessed by autoradiography using flash. 
prcactivutctl XJhxu film (Kodak). Trncks A, B and C tvc 
i~nmuanpreeipitatc~ from control, CAMP- and ECWtreetsd cell 
extrnrts, rcapcctivcly. PK indicates the position of pyrnvate kinttsc. 
[a], enzyme activities were measured at high phospho- 
enolpyruvace concentrations. In experiments on three 
separate cell pref.arations, the basal incorporation of 
phosphate into pyruvatc kinase (expressed as man 
cpm/U enzyme activity immunoprecipitated f SE) was 
91.1 rt 18.9. Incubation of hcpatocytcs with 
ClPhScAMP or EGF for 10 min increased the 
phosphorylation of the enzyme to 159.0 * 17,8 (PC O,OS 
vs control) and 18&O& 32.1 (PcO.01 vs control), 
respectively. When added together, the two effecters 
did not produce an additive effect on phosphate incor- 
poration into pyruvate kinase (163-O* 20,3; PcO.01 vs 
control). 
The results sh(:)wn in Fig. 2 indicate that the time 
courses of the effects of EGF and cyclic AMP on 
pyruvate kinase phosphorylation differ significantly. 
While the phosphorylation of the enzyme in response to 
cAIvIP was apparent almost immediately (see also [ 1 l]), 
maximal phosphorylation by EGF was attained only 
after approximately 10 min. Under control conditions 
with no added effecters, the phosphorylation of 
pyruvate kinase did not alter significantly (results not 
shown). The time course for the phosphorylation of 
pyruvate kinase by EGF is broadly consistent with those 
for the stimulation of gluconeogenesis and inactivation 
of the enzyme by EGF (see [S]). The difference in the 
time courses for BGF and cyclic AMP, together with 
the fact that XXI; does not insrease the intracellular 
concentration of cyclic AMP [5,8], indicates that the 
two effecters alter; the phosphorylation 
zyme via largely separate mechanisms. 
In order to further investigate the 
phosphsrylation ‘of pyruvate kinase, 
state of the en- 
EGF-mediated 
phosphoamino 
Fig. 2. Tim EOWIC far O\c phosphorylnlion 0f pyruvmc kina% by 
ECZ. Cell extracts wcrr prepared from ‘*PM~llcd hcparocytca 
ineubafcd wirh 110 further ndtlitions (O), EGF (Q) or CAMP (ls) for 
the limes shown. The dcgrcc of “P-incorporation into pyruvarc 
kinasc wa asscsrcd ,IS dcscribcd in the ICXI. The results sh0wn arc the 
avcrayc of cxpcrimcnrs on three scpnratc cell prcpnralionx *SE. 
acid analysis of the enzyme was undertaken. Initial 
analysis of the acid hydrolystaes atpH 3.5 ruled out the 
possibility that EGF increased phosphate incorporation 
on tyrosine residues. High voltage lectrophotesis at pH 
1.9 showed that EGF, like CAMP, increased the 
phosphorylation of serine residues in pyruvate kinasc 
(Fig. 3). Phosphothreonine was not detested. 
The results presented here show that EGF inactivates 
hepatic pyruvate kinase by increasing the phosphoryla- 
tion of the enzyme on serine residues. Pytuvate kinase 
is phosphorylared by CAMP-dependent protein kinase 
on serine- 12 [ 1%). The enzyme has also been shown to be 
phosphorylated by Ca2’/calmodulin-dependent pro- 
tein kinase in vitro on serine-i:! and, to a lesser extent, 
on threonine-17 1131. In intact hepatocytes only 
phosphorylation on serine-12 is seen in response to 
Ca”-linked hormones (141. Although we have not fully 
charasterised the EGF phosphorylation site on pyruvate 
kinase, the lack of additivity with cyclic AMP and the 
fact that EGF has the same effect on the activity of the 
enzynle as cyclic AMP may suggest that EGF increases 
the phosphorylation of serine-12. 
It is unlikely that the effect of EGF on pyruvate 
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Fig. J. Pho~phurmino acid nna\y!,i~ of ghoaphsrylsred pyruvnrc 
kinasc, CM r?xIrxIs wcrc prcparecl from “P-labellcd hcpatocytcs 
incubated with ECP or CAMP for IO min. Phosphormino acid 
analysis wn~ enrricd oul asdc$cribcd in xrclion 2. Traeka shown on the 
;lutorndiogxph are sa follsws: (I) phosphotyroainc; (2) 
phaxghothrconinc; (3) phoaphorcrine; (4), (5) and (6) acid 
hydrolyaatcn of immunoprcsipi~irlcr from control, CAMP and EGF 
cell exrrear, respcctivcly; and (7) alI rhrcc sfnndnrd phorphoamino 
acids together. 
kinase is mediated via an increase in the activity of 
CAMP-dependent protein kinase as it has been 
established that EGF has no measurable ffect on the 
intracellular concentration of cyclic AMP [5,$]. In 
hcpatocytes, as in a number of other cell types, EGF- 
like vasopressin produces a rapid increase in in- 
tracellular Ca*+ concentrations. In contrast to 
vasopressin, however, the EGF-induced Ca2’ increases 
are smaller and transient, with levels returning to nor- 
mal within 5 min [5,15]. The EGF-stimulated 
phosphorylation of pyruvate kinase is unlikely to be 
mediated by Ca2+/calmodulin-dependent protein 
kinase as the increase in phosphorylation occurs 
predominantly after the Ca*’ transient has disap- 
peared. In addition, the effect of EGF on pyruvate 
kinase phosphorylation is much slower than the effect 
of vasopressin which is maximal after only three 
minutes [14]. 
While effects of EGF on CAMP-dependent protein 
kinase or Ca”/calmodulin-dependent protein kinase 
cannot be entirely excluded at this stage, it seems likely 
that EGF exerts its effects on pyruvate kinase through 
activation of some other, as yet undefined, serine pro- 
tein kinase. It is interesting to note that phosphoryla- 
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